Acute Non Lymphoblastic Leukemia in the Department of Child Health School of Medicine, University of North Sumatera/ Dr. Pirngadi Hospital Medan (1983-1988): A Preliminary Study
Abstract
A retrospective study on Acute Non Lymphoblastic Leukemia (ANLL) was conducted at the Sub Division of Pediatric Hematology, School of Medicine, University of North Sumatera/Dr. Pirngadi Hospital Medan, in a period of 5 years (1983-1988).
There were 18 cases consisted of 14 (77. 78%) males and 4 (22 .22%) females with the age group of 0-2 years: 6 (30%), 2-8 years: 9 (50%), 8-15 years: 3 (30%). By the FAB classification, they were of FAB M-1: 1 (5.55%), FAB M-2: 1 (5.55%), FAB M-3: 1 (5.55%), FAB M-4: 2 (11.12%) and FAB M-6: 13 (72.23%). Only 7 (38.88%) were treated with cytostatics while the others received only supportive therapy. The result of cytostatic treatment was unsatisfactory: 4 (57.14%) died within the first 2 months of treatment, 3 (42.86%) discontinued their cytostatics treatment.
References
2. KOBRINSKY, N.L.; ROBISON, L.L.; NESBIT, M.E.: Acute Nonlymphocytic Leukemia. In the Pediatric Clinics of North America. Altman, A.J.
3. LEVENTHAL BG. Neoplasm and Neoplasm. Nelson Text Book of Pediatrics 13th ed, Philadelphia: WB Saunders, 1987: 1079-110.
4. HERMANN J, PLENERT W! ZINTL F, et al. Improved Treatment Result in Childhood Non Lymphoblastic Leukemia with the BFMAML Protocol 78 in a Multicenter Study in the GDR; in BUCHNER, SCHELLONG, HIDDEMANN, URBANITZ, RITTER, eds, Haematology and Blood Transfusion, Berlin, Heidelberg: Springer-Verlag, 1987: 76-82.
S. WEINSTEIN H, GRIER H, GELBER R, CAMITTA B, LINK M, DELOREY M, PRICE K. Psotremission Induction Intensive Sequential Chemotherapy for Children with AML – Treatment Results and Prognostic Factors; in BUCHNER, SCHELLONG, HIDDEMANN, URBANITZ, RITTER, eds, Haematology and Blood Transfusion, Berlin, Heidelberg: SpringerVerlag, 1987: 88-92.
Copyright (c) 2019 Feraluna Nasution, Zairul Arifin, Adi Sutjipto
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Published 2019-02-01